High risk pregnancy: Raised blood pressure Flashcards

1
Q

Define Mild, Moderate and Severe hypertension.

A

Mild hypertension diastolic blood pressure 90–99 mmHg, systolic blood pressure 140– 149 mmHg.
Moderate hypertension diastolic blood pressure 100–109 mmHg, systolic blood pressure 150–159 mmHg.
Severe hypertension diastolic blood pressure 110 mmHg or greater, systolic blood pressure 160 mmHg or greater.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Chronic hypertension

A

Chronic hypertension is hypertension that is present at the booking visit or before 20 weeks or if the woman is already taking antihypertensive medication when referred to maternity services. It can be primary or secondary in aetiology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define Eclampsia

A

Eclampsia is a convulsive condition associated with pre-eclampsia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define HELLP syndrome

A

HELLP syndrome is haemolysis, elevated liver enzymes and low platelet count.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define Gestational hypertension

A

Gestational hypertension is new hypertension presenting after 20 weeks without significant proteinuria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define Pre-eclampsia

A

Pre-eclampsia is new hypertension presenting after 20 weeks with significant proteinuria.
Severe pre-eclampsia is pre-eclampsia with severe hypertension and/or with symptoms, and/or biochemical and/or haematological impairment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pre conception counselling for women with hypertension

A

Tell women who take angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs):
• that there is an increased risk of congenital abnormalities if these drugs are taken during pregnancy
• to discuss other antihypertensive treatment with the healthcare professional responsible for managing their hypertension, if they are planning pregnancy.
2. Stop antihypertensive treatment in women taking ACE inhibitors or ARBs if they become pregnant (preferably within 2 working days of notification of pregnancy) and offer alternatives.
3. Tell women who take chlorothiazide:
• that there may be an increased risk of congenital abnormality and neonatal complications if these drugs are taken during pregnancy
• to discuss other antihypertensive treatment with the healthcare professional responsible for managing their hypertension, if they are planning pregnancy.
4.Tell women who take antihypertensive treatments other than ACE inhibitors, ARBs or chlorothiazide that the limited evidence available has not shown an increased risk of congenital malformation with such treatments.
Diet
• Encourage women with chronic hypertension to keep their dietary sodium intake low, either by reducing or substituting sodium salt, because this can reduce blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline risk factors for pre-eclampsia

A
Moderat risk
Nulliparity
age 40 or older
pregnancy interval of more than 10 years
family hx pre-eclampsia
multiple pregnancy
BMI >35kg/m2 or more 
High risk
Hypertensive disease during previous pregnancy
Chronic kidney disease
Autoimune diease such as SLE or APLS
Type 1 or 2 diabeties
chronic hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Modified Panderson hypothesis - effects of diabetes on the foetus

A

Maternal Hyperglycemia–> Fetal Hyperglycemia–>
–> Fetal pancreatic beta cell –> Hyperplasia Fetal –>Hyperinsulinaemia

Leads to 
Macrosomia
Organomegaly 
Polycythaemia 
Hypoglycaemia 
RDS 
Jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Physiological changes in glucose tolerance in pregnancy

A
  • physiological insulin resistance and relative glucose intolerance
  • Altered Glucose handling
  • 2nd and 3rd trimester progressive insulin resistance
    Normal woman doubling of insulin production
  • diabetic women insufficient secretion to compensate for insulin resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Preconception Planning & Care for diabetic patients

A
  • Avoid unplanned pregnancy
  • Lose weight if BMI >27
  • Take folic acid 5mg till 12 weeks pregnant
  • Maintain fasting plasma glucose level of 5–7 mmol/litre on waking and a plasma glucose level of 4– 7 mmol/litre before meals at other times of the day.
  • Advise women with diabetes who are planning to become pregnant to aim to keep their HbA1c level below 48 mmol/mol (6.5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors and diagnosis for gestational diabetes

A

Risk factors:
• BMI above 30 kg/m2
• previous macrosomic baby weighing 4.5 kg or above
• previous gestational diabetes
• family history of diabetes (first-degree relative with diabetes)
• minority ethnic family origin with a high prevalence of diabetes Diagnosis:
• a fasting plasma glucose level of 5.6 mmol/litre or above or
• a 2-hour plasma glucose level of 7.8 mmol/litre or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antenatal care for Women with Diabetes

A

• Offer immediate treatment with insulin, with or without metformin, as well as changes in diet and exercise, to women with gestational diabetes who have a fasting plasma glucose level of
7.0 mmol/litre or above at diagnosis
• Consider immediate treatment with insulin, with or without metformin, as well as changes in diet and exercise, for women with gestational diabetes who have a fasting plasma glucose level of between 6.0 and 6.9 mmol/litre if there are complications such as macrosomia or hydramnios.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intrapartum Care for patients with diabetes

A
  • Women with type 1 or type 2 diabetes and no other complications –an elective birth by IOL, or by El C/S if indicated, b/w 37+0 - 38+6
  • Elective birth before 37+0 weeks – with type 1 or type 2 diabetes if there are metabolic or any other maternal or fetal complications
  • Advise women with GDM to give birth no later than 40+6 weeks, and offer elective birth (by IOL, or by C/S if indicated) if not given birth by this time.
  • Consider elective birth before 40+6 weeks for women with GDM if there are maternal or fetal complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Differential diagnosis of epilepsy in women.

A

• The diagnosis of epilepsy and epileptiform seizures should be made by a medical practitioner with expertise in epilepsy, usually a neurologist.
• Women with epilepsy (WWE), their families and healthcare professionals should be aware of the different types of epilepsy and their presentation to assess the specific risks to the mother and baby.
• Differential Diagnosis:
1. Eclampsia management until a definitive diagnosis is made by a full neurological assessment.
2. cardiac,
3. metabolic
4. intracranial conditions
5. Neuropsychiatric conditions including non-epileptic attack disorder should also be considered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the Clinical presentation of Tonic-clonic seizures and the
Effects on mother and baby

A

Dramatic events with stiffening, then bilateral jerking and a post-seizure state of confusion and sleepiness. Sudden loss of consciousness with an an uncontrolled fall without prior warning. Associated with a variable period of fetal hypoxia.This seizure type is associated with the highest risk of SUDEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the Clinical presentation of Absence seizures and the
Effects on mother and baby

A

Generalised seizures that consist of brief blank spells associated with unresponsiveness, which are followed by rapid recovery.
Effects mediated through brief loss awareness although physiological effects are modest. Worsening absence seizures place the woman at high risk of tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the Clinical presentation of Juvenile myoclonic epilepsy and the
Effects on mother and baby

A

Myoclonic jerks are the key feature of this form of epilepsy and often precede tonic-clonic convulsion. These jerks present as sudden and unpredictable movements and represent a generalised seizure. Occurs more frequently after sleep deprivation and in the period soon after waking or when tired. The sudden jerks may lead to falls or to dropping of objects including the baby.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the Clinical presentation of Focal seizures, (previously defined as ‘complex partial’ if seizure impair consciousness and ’simple partial’ if consciousness not impaired).and the
Effects on mother and baby

A

Symptoms are variable depending on the regions and networks of the brain affected. Within an individual, the attacks are recognisable and stereotypical. Seizures may impair consciousness. Primary focal seizures can undergo secondary generalisation. An aura is a primary focal seizure.
Impairment of consciousness increases risk of injury such as long bone fracture, dental or head injury, electrocution or burns seizures compared with if consciousness is retained ( an epileptic aura only). They can be associated with a variable period of hypoxia and risk of SUDEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the effect of pregnancy on seizures in WWE?

A
  • Inform that two-thirds will not have seizure deterioration in pregnancy.
  • Pregnant women who have experienced seizures in the year prior to conception require close monitoring for their epilepsy.
  • WWE should be provided with verbal and written information on prenatal screening and its implications,the risks of self- discontinuation of AEDs and the effects of seizures and AEDs on the fetus and on the pregnancy, breastfeeding and contraception.
  • WWE should be informed that the introduction of a few safety precautions may significantly reduce the risk of accidents and minimise anxiety.
  • Healthcare professionals should acknowledge the concerns of WWE and be aware of the effect of such concerns on their adherence to AEDs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Phsyiological changes in thyroid function in pregnancy

A

Pregnancy - no change in TSH, free T4 and free thyroxine but increase in total T4 and T3.

Hyperthyroidism - decerase in TSH. increase in free T4, free thyroxine, Total T4 and total T3.

Hypothyroidism - increase in TSH, decrease in everything else.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Effect of hyperthyroidism in pregnancy.

A

•Thyrotoxicosis improves in second and third trimester
•If untreated, risk of miscarriage, fetal growth restriction, preterm labour and perinatal mortality.
Note in relation to pregnancy:
•Stimulation of thyroid by HCG•Reduced plasma iodine concentration•Increase in thyroid binding globulin –Less free T4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Management if hyperthyroidism.

A
  • Carbimazole 15-40mg or Propylthiouracil 150-400mg for 4-6 weeks. •Dose then reduced to 5-15 mg for Carbimazole and 50-150 mg for PTU. •Β-blockers
  • Surgery
  • Radioactive iodine (contraindicated in pregnancy and breastfeeding).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

effect of hypothyroidism on pregnancy.

A

no effect if treated. if untreated risk of miscarried, anaemia, pre eclampsia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Thyroid storm symptoms and signs.

A

fever,
tachycardia out of proportion to the fever, normal blood pressure, high output cardiac failure ,
restlessness, coma, seizures,
gastrointestinal: pain, diarhoea, vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

thyroid storm management and treatment

A

TFTs should be taken prior to treatment and the endocrinology registrar called. The patient should be admitted to hospital.
Treatment
large doses of PTU or carbimazole, potassium iodide or
sodium iodide, dexamethasone , propanolol and phenobarbitol. Supportive therapy with iv fluids, oxygen and antipyretics should be administered

27
Q

Outline POST PARTUM THYROID DYSFUNCTION

A
  • Transient thyroid dysfunction occurs in about 5-10% of women.
  • The incidence is higher in women with existing endocrinological disease, eg IDDM.
  • Classically there is transient hyperthyroidism, at 6-12 weeks postpartum followed by hypothyroidism. 80% resolve in 6-9 months.
  • Some need long term thyroxine replacement.
  • This should be managed by endocrinologists.
28
Q

Outline physiological changes in respiratory physiology in pregnancy

A

Oxygen consumption
Inc 20%

Metabolic rate
Inc 15%

Resting Minute Ventilation
Inc 40-50%

Tidal Volume
Inc

Respiratory rate
unchanged

Functional Residual Capacity
Dec 3rd trimester

Vital Capacity
Unchanged

FEV1, PEFR
Unchanged

PaO2
Inc

PaCO2
Dec 4.0 k Pa/30mmHg

Arterial Ph
Inc 7.44

29
Q

Tuberculosis in pregnancy management

A

Postnatal
Mum non infectious 2 wks of beginning Rx,
If Mun sputum positive, treat neonate with isoniazid Can breast feed
Baby needs BCG vaccination

30
Q

CF in Pregnancy - counselling

A
  • Pre pregnancy counselling is essential.
  • Safe in mild dx FEV1>70-8-% predicted
  • Contraindicated: p HTN, Cor pulmonale, FEV1 < 30-40& predicted
  • Screen for DM
  • Determination of carrier status of partner. Risk to child is 50% if partner is HZ, 2- 2.5% if carrier status of partner unknown
  • Joint care with CF centre, specialist dietary advice, aggressive rx of infections
  • IOL may be necessary and Preterm delivery rates are high. Perinatal outcome is usually good.
31
Q

Physiological cardiac changes in pregnancy.

A

Cardiac output
INC, 40%

Stroke volume
INC

Heart rate
INC 10-20bpm

BP
DEC 1st & 2nd trimester, same or inc in 3rd trimester.

32
Q

List examples of Congenital Heart disease

A
• PDA
• ASD
• VSD
• Congenital AS
• Coarctation of Aorta
• Marfan’s
Congenital Heart disease
• Cyanotic CHD: Pulmonary Atresia, Tetralogy of Fallot
33
Q

intrapartum Management of congenital or acquired cardiac disease

A

MDT approach
Planned mode and place of delivery Use of uterotonics:
Ergometrine ( vasoconsyriction) avoided in CAD/ Coarc or risk of aortic dissection
Syntocinon ( vasodilation) avoid or give slowly in stenotic lesion/ HCM Iv fluids and anticoagulation

34
Q

List examples of acquired heart disease

A
  • Mitral Stenosis
  • Cardiomyopathy : Hypertrophic/ Peripartum cardiomyopathy
  • Artificial Heart Valves
  • MI / Acute coronary Syndrome
  • Dissection of thoracic aorta
  • Arrhythmias
35
Q

How do you structure your initial call for help in a obstetric emergency>

A
  • PULL emergency bell
  • State your emergency “Postpartum haemorrhage”
  • Ask the first appropriate person to enter the room to dial 2222. State “Obstetric Emergency” and the area and location “Labour ward, Room 6”
  • Ask them to come back to you and confirm this has been done
  • Request equipment required e.g. PPH trolley and drugs, resuscitaire.
36
Q

Outline your A-E in an obstetric emergency

A
Airway
• Is she talking?
• Signs of obstruction- what can you hear?
• Position- bed away from wall, end of bed removed
• Flat bed/left lateral
B
• Resps,SATS
• ApplyO2-Whichmask?
• Signs of worker breathing
• Position
Circulation
• Pulse, BP, Colour, cap refill, cold peripheries?
• IV Access, Bloods, Fluids ? Which
• Urine output- ? Catheter needed
Disability
• AVPU- any concerns? • Blood sugar
• Potential drug cause?
Exposure
• Headtotoeassessment • Temperature
• ReviewABCDE

Record Keeping
• Delegate an appropriate SCRIBE
it may be more appropriate for a senior member of staff to be the
scribe as they can step back, observe and manage the situation using the proforma as a prompt
• Use specific PROFORMA if available – where are they?
• Tell your scribe what you want them to write;
persons present and roles, timings, drugs and doses given, manoeuvres
used
• Clear and legible
• As contemporaneous as possible

37
Q

Why is sepsis identification and treatment of sepsis so important in obstetrics?

A
  • 4th leading cause of direct maternal death
  • Severe sepsis 30% mortality rate in maternity
  • NICE have automatically categorised all pregnant women up to 6 weeks postnatal as high risk for sepsis (due to cardiovascular and immune system changes)
  • Pregnant women compensate for longer as they are generally healthier and have more reserves
  • Strep A and e-coli are most common causes of sepsis in maternity
38
Q

What is the difference between cord prolapse and cord presentation?

A

Cord presentation is the presence of the umbilical cord between the fatal presenting part and cervix with or without ruptured membranes

cord prolapse is when the umbilical cord descends through the cervix alongside or past the presenting metal part in the presence of ruptured membranes

39
Q

Risk factors for cord prolapse

A
Pregnancy related
• Unengaged presenting part
• Multiple pregnancy
• Multiparity
• Malpresentation, malposition
or unstable lie
• Polyhydramnios
• Prematurity
• Low lying placenta
• Fetal congenital abnormality

Procedure related
• ARM
• ECV
• Controlled ARM for IOL with
high head
• Rotational Instrumental delivery • Vaginal manipulation of the
fetus with ruptured membranes eg. application of FSE

40
Q

Management of cord prolapse

A
  • If membranes intact, STOP VE to avoid ARM
  • Exaggerated SIMS
  • Monitor fetal heart
  • Escalate
  • Consider operative birth
41
Q

Outline management of eclampsia

A
SUPPORT AIRWAY
Left lateral position
BREATHING
Administer high flow oxygen
CIRCULATION
IV access and bloods
CONTROL SEIZURES
Magnesium Sulfate Loading Dose
4g IV over 5-10 minutes
Magnesium Sulfate Maintenance Dose 1g/hr IV for at least 24 hours after last seizure
Recurrent seizures
2g bolus IV over 10 minutes
42
Q

what s the dosage of magnetism sulphate used to treat pre-eclampsia (loading and maintenance dose

A

LOADING DOSE
4g pre-diluted 20 % Magnesium
Sulfate
Draw up 20ml of 20% Magnesium Sulfate (from the 20ml vial) into a 20ml syringe and give over 5-10 minutes

MAINTENANCE DOSE
1g/hour pre-diluted 20 % Magnesium Sulfate
Draw up 50ml (10g) of 20% Magnesium Sulfate (from the 50ml vial) into a 50ml syringe and give at a rate of 5ml/hour (1g/hour) for 24 hours.

43
Q

What should you check in an eclectic patient while being treated with magnesium sulphate?

A

• Ensure that patella reflexes are present every 30 minutes for the first two hours and then hourly. If they are depressed or absent stop magnesium infusion and check magnesium levels.
• Check respiratory rate hourly. If less than 10, stop infusion and check magnesium levels.
• Ensure oxygen saturation is >94%. If saturation is lower than 94%, administer oxygen, listen to the lungs (risk of pulmonary oedema), stop infusion and check magnesium levels.
BP and pulse every 15 minutes after loading dose for 1 hour
then every 30 minutes thereafter.
Commence a strict fluid balance
• Ensure urine output is more than 20mls/hour (If less monitor creatinine levels to inform care)
• Restrict fluid intake to 1ml/kg/hr
Check blood magnesium levels if symptoms of toxicity;
• Therapeutic levels are 2-4 mmol/l

44
Q

What is the antidote to magnesium sulphate?

A

Give (1g) 10ml 10% calcium gluconate IV slowly over 10 minutes
Intubate and ventilate.
Send blood for Magnesium level to lab urgently. Calcium gluconate should only be given under Consultant/Registrar supervision.

45
Q

Define shoulder dystocia

A

impaction of the fatal shoulder against the maternal symphysis pubis after the fatal head has delivered and is diagnosed when man overs used to deliver the fatal shoulders after normal dental downward traction has failed

46
Q

Risk factors for shoulder dystocia

A
  • Conventional risk factors predict only 16% of shoulder dystocia that resulted in infant morbidity
  • Previous SD (10x higher risk)
  • Macrosomia (weak predictor)
  • Maternal diabetes
  • Obesity
  • Prolonged 1st stage
  • Prolonged 2nd stage
  • Labour augmentation
  • Instrumental delivery
47
Q

How would you manage shoulder dystocia?

A

Mcrobertes position
apply supra pubic pressure for 30 seconds and try rocking motion
discourage maternal effort

48
Q

Outline breech first stage management

A
  • Continual care and support
  • Monitor progress in labour is as expected for their parity
  • Upright maternal position to aid decent
  • Consider VE after SROM to exclude cord prolapse
  • Continuous CTG
  • Expect Meconium- Vigilance to assess cause,? Compression or pathological response
  • Choice of analgesia- no evidence to advise epidural
49
Q

Outline breech second stage management

A

• VE is indicated to confirm full dilatation- this is particularly important for the preterm breech
• Allow passive decent with maternal effort- await visualisation at the perineum before active pushing is encouraged
• Ensure continuous CTG
• Consider position- end of bed removed
• HANDS OFF!! Avoid traction on the breech
• Paediatrician must be present
Remember- Breech 2nd Stage is more stressful for the fetus due to cord compression as the trunk descends through the pelvis

50
Q

List risk factors for PPH

A
Pre-labour
• Previous PPH/retained placenta
• Previous CS
• Placenta praevia/accreta/percreta
• APH, especially from placental abruption
• Overdistension of uterus
• Pre-eclampsia
• BMI >35
• Increased maternal age
• Fibroids/abnormalities
• Hb<9
• Grand multip
Intrapartum
• IOL
• Prolonged 1st, 2nd or 3rd stage
• Oxytocin use
• Retained placenta
• Precipitate labour
• Operative vaginal delivery
• CS (particularly 2nd stage)
• Abruption
• Pyrexia in labour
51
Q

PPH: Outline drugs used to manage uterine tone.

A

oxytocin 10 units
ergometrine 500 micrograms
syttometrine 1 amp
oxytocin infusion 40 units in 500 mrs normal saline
haemabate (carboprost) 250 micrograms IM every 15 mins max 8 doses
Misoprostol 800mcg sublingual or 1000 mcgPR

52
Q

PPH: Outline steps to manage bleeding surgically

A
EUA
Perineal repair
MROP
Rusch ballon
B Lynch suture
uterine artery embolism
Hysterectomy
53
Q

PPH: Outline steps to manage coagulopathy

A
Blood products:
Cryoprecipitate
platelets
FFP
RBC

Tranexamic acid
1g IV over 10 mins

54
Q

When is the highest risk of eclamptic fits?

A
  • Postpartum 44%
  • Antepartum 38%
  • Intrapartum 18%
55
Q

Most common cause of death in eclampsia

A

Most common cause of death is cerebral haemorrhage

56
Q

Outline Initial response to eclamptic fit

A

Call for help
•Monitory her Airway/Breathing and Circulation
•Left lateral position /30 degree tilt or manual displacement of uterus
•High flow oxygen by facemask with a bag
•Insert two wide bore grey cannula on both sides and take bloods at same time -FBC,group and save, LFT, U&Es and clotting

57
Q

Drug treatment of eclamptic fit

A

MgSO4 is the only drug of choice
•Loading dose -4gm intravenously over 5-10 minutes
•Maintenance dose - 1gm/hr maintained for 24hrs
•Recurrent seizures- 2-4gm given over 5 minutes

58
Q

Women on MgSO4 for eclampsia should have a clinical review every 4 hours.

What features should be evaluated?

A
  • Respiratory rate
  • Urine out put (MgSO4 is excreted through kidneys)
  • Reflexes
  • Blood pressure
  • Oxygen saturations
  • Strict input / out chart should be maintained - risk of pulmonary oedema
NOTE: toxicity indicated by 
•Motor paralysis
•Absent reflexes
•Respiratory depression
•Cardiac arrhythmias /cardiac arrest
59
Q

Clinical features of Magnesium Sulphate toxicity

A
  • Motor paralysis
  • Absent reflexes
  • Respiratory depression
  • Cardiac arrhythmias /cardiac arrest
  • Therapeutic range of MgSO4 – 2-4 mmol/l
60
Q

Women on MgSO4 for eclampsia should have a clinical review every 4 hours.

What is the Antidote for MgSO4?

A

10 ml of 10% calcium gluconate intravenously over 10 minutes

61
Q

How is blood pressure controlled in women with eclampsia?

A
  • Aim - blood pressure should be reduced to <160/105 (MAP <125 mmHg)
  • labetalol 200mg (oral or intravenous infusion)
  • Hydralazine –intravenous boluses
  • Nifedipine 10mg oral
62
Q

Management of labour in women with eclampsia

A
  • Continuous intrapartum fetal monitoring
  • Epidural analgesia is encouraged
  • Measure BP every 15 minutes
  • Safe for mother to have normal active second stage unless very high BP or symptomatic of severe headache or visual disturbances
  • Ergometrine or syntometrine is contraindicated!
63
Q

How should the third stage of labour be managed women with eclampsia?

A
  • Ergometrine or syntometrine is contraindicated
  • Syntocinon 10 units intravenously or intramuscular
  • Syntocinon infusion- 40 units in 500ml of normal saline @ 125ml/hour
64
Q

Key components of post natal care for women with eclampsia?

A
  • Close monitoring of BP for next 72 hours
  • Risk of pre-eclampsia in next pregnancy is 25%
  • Low dose aspirin 75mg in next pregnancy to reduce risk of pre eclampsia
  • VTE scoring and thrombo-prophylaxis
  • Breast feeding is safe